INTRODUCTION
Endogenous Cushing's syndrome (CS) is a clin ical state resulting from prolonged, inappro priate exposure to excessive cortisol secretion with a subsequent loss of the normal feedback mechanism of the hypothalamopituitary adrenal axis and the normal circadian rhythm of cortisol secretion. The etiology of CS may be excessive adrenocorticotrophin (ACTH) production, most commonly from a pitui tary adenoma, or from a nonpituitary tumor (ACTHdependent CS) or less often excessive autonomous secretion of cortisol from a hyper functioning adrenocortical tumors and bilat eral adrenal hyperplasia (ACTHindependent CS). The diagnosis of CS remains a considerable challenge in clinical endocrinology [1] .
CASE REPORT
A 38yearold woman was admitted to our Clinic for Endocrinology, Diabetes and Metabolic Diseases with suspected ectopic CS. At 33 years of age she was hospitalized at a regional hospital because of the appearance of purple striae, hirsutism, oligomenorrhea, high blood pressure and high blood glucose. The diagnosis of ACTHdependent CS was made (cortisol=1017 nmol/l; absence of circa dian rhythm of cortisol secretion 776/759/761 nmol/l; failure to suppress cortisol in lowdose dexamethasone suppression tests (DST 1 mg, cortisol=579 nmo/l; ACTH=87.2 pg/ml). A computed tomography (CT) of the abdomen and chest, as a magnetic resonance imaging (MRI) of the sellar region recorded regular find ings. At 35 years of age CRH test was done at the regional hospital (3 values without specify ing the time of sampling; ACTH=148/150/130 ng/l; cortisol=1224/1121/1033 nmo/l), and the diagnosis of ectopic CS was passed. Since then, the patient has been regularly on ketocon azole which was withdrawn two months before admission to our Clinic. She gave birth at 19 years of age. The father died of lung cancer, and the grandfather had lymphoma. The patient did not consume alcohol and was an exsmoker.
On examination she presented typical somatic symptoms of hypercortisolemia ( Figure  1 ): dry skin, easy bruising, facial plethora and fullness, violaceous striae, dorsocervical and supraclavicular fat pads, truncal obesity and hirsutism (FerrimanGallway score was 13). Visible mucous membranes were of normal color. The patient's hypertension was under control with antihypertensive drugs. The remainder of the physical examination revealed no abnormalities.
SUMMARy Introduction
Cushing's syndrome results from inappropriate exposure to excessive glucocorticoids. Untreated, it has significant morbidity and mortality. Case Outline A 38yearold woman with a typical appearance of Cushing's syndrome was admitted for further evaluation of hypercortisolism. The serum cortisol level was elevated without diurnal rhythm, without adequate suppression of cortisol after 1 mg dexamethasone suppression test. 24hour urinary free cortisol level was elevated. Differential diagnostic testing indicated adrenocorticotrophin (ACTH) dependent lesion of the pituitary origin. Pituitary abnormalities were not observed during repeated MRI scanning. Inferior petrosal sinus sampling (IPSS) was performed: 1) Baseline ratio ACTH inferior petrosal sinus/peripheral was <2; 2) Corticotropinreleasing hormone (CRH) stimulated ratio ACTH inferior pet rosal sinus/peripheral was <3; 3) Baseline intersinus ratio of ACTH was <1.4; 4) Increase in inferior pet rosal sinus and peripheral ACTH of more than 50 percent above basal level after CRH; 5) Baseline ratio ACTH vena jugularis interna/peripheral was >1. Repeated MRI of the sellar region (splitting into 3 mm sections in spin echo sequences T1W, T2W and PD) were unable to give clearcut evidence for a pituitary neoplasm.
The next step was bilateral simultaneous inferior pet rosal sinus sampling (IPSS) with CRH administration. IPSS yielded the following results: 1. Central/ peripheral (C/P) ACTH ratios at the level of sinus petrosus inferior (SPI), before the administration of CRH was< 2 (C/P=1.1) 2. C/P ACTH ratios at the level of SPI after the administration of CRH was <3 (C/P=1.3) 3. Intersinus ratio left: dextral (L:D) was <1.4 (L:D=1.3) 4. Increment in levels of ACTH above the baseline level exceeded 50% at the level of SPI (128.8%) and at the level of periphery (80.3%) after the administration of CRH 5. C/P ACTH ratios at the level of internal jugular vein (IJV) was >1.7 (1.9) At the Clinic of Neurosurgery, the exploration of the pituitary gland by transsphenoidal approach and surgi cal removal of adenoma was done. Histological findings showed many small fragments of yellowish color, one of which showed signs of some degree of atrophy. Signs of compression atrophy would indirectly indicate a possibility of adenoma, which was probably aspirated during surgery.
Postoperative followup during 2 years showed biochem ical and clinical remission (Figure 2 ) of CS (ACTH<1.0 ng /l, cortisol=13.5 nmol/l). Due to the development of iat rogenic hypopituitarism, the patient was put on adequate hormone substitution with hydrocortisone, levothyrox ine, estroprogestagen therapy without treatment for dia betes and hypertension. There were no signs of diabetes insipidus.
DISCUSSION
ACTHdependent CS (accounts for 8085% of cases of endogenous CS) includes Cushing's disease and ectopic ACTH/CRH syndrome. Cushing's disease is defined as a specific type of CS due to excessive pituitary ACTH secretion from a pituitary tumor. This is the most frequent type of CS and is responsible for about 70% of reported cases. Cushing's disease is much more common in women than in men (female:male ratio of about 8:1) and the age at diagnosis is usually 20-40 years. Nonpituitary ACTH secreting tumors are mostly neuroendocrine tumors; carcinoid (bronchial, pancreatic, thymic, intestinal, ovarian) pancreatic islet cell tumors, medullary thyroid cancer, as well as more aggressive malignant tumors. Carcinoma with ectopic ACTH secretion appears more frequently in men and the peak age incidence is 40-60 years. It is characterized by abrupt onset of pronounced hypercorticism, with hyperpigmentation, hypokalemia, alkalosis, loss of weight and anemia. Less aggressive neuroendocrine tumors with ectopic ACTH secretion have a slower clinical course, with clinical presentation and response to standard dynamic hormonal tests as ACTH secreting pituitary adenoma. Hyperpigmentation, hypokalemic alkalosis and anemia may not always be present. Ectopic CS is associated with a cosecretion of other hormones and peptides; carcinoembryonic antigen, somatostatin, chromogranin A, calcitonin, gastrin, glucagon, vasoactive intestinal peptide, alphafetoprotein and others, which can be important in the differential diagnosis of ACTHdependent CS. Our patient was a young woman with clinical signs of hypercorticism and without electrolyte disorders.
Hormonal diagnosis of endogenous CS includes an excessive chronic cortisol secretion, loss of the normal cir cadian rhythm of cortisol secretion and lack of suppres sion by exogenous steroids [1, 2] .
Firstline diagnostic tests for the diagnosis of CS are: 1. UFC; UFC values 4fold higher than the upper limit of normal can be considered diagnostic for this condition (sensitivity (SZ) 95100%, specifity (SP) 98%). 2. DST1mg; SZ 98%, SP 87,5%, plasma cortisol below 50 nmol/l excludes active CS at that time. 3. Latenight (23 hrs) salivary cortisol; SZ i SP 9095%, salivary cortisol below 4.3 nmol/l excludes active CS at that time. Secondline diagnostic tests for the diagnosis of CS are: 1. Plasma cortisol circadian rhythmmidnight plasma cortisol; plasma cortisol is above a cutoff value of 50 nmol/l when measured at midnight in hospitalized, sleeping CS patients, SZ 100%, SP is lower. 2. LDDST; normal response consists of plasma cortisol to less than 50 nmol/l in the morning after the last dose of dexamethasone, SZ and SP 97100%, 3. combined LDDST/CRH test in distinguishing CS from pseudoCS. Plasma cortisol value 15 min after CRH is over 38 nmol/l in patients with CS, but remains suppressed in normal individuals and in patients with pseudoCS.
Once Cushing's syndrome has been diagnosed the next step is to determine whether the pathologic state is ACTHdependent with the location of the site of ACTH overproduction, or ACTHindependent. Differential diag nostic tests are:
1. ACTH measurement a) ACTH values below 5 or 10 pg/ml suggest an ACTH independent cause of CS b) ACTH values between 10 and 20 or 5-10 pg/ml require additional differential diagnostic testing c) ACTH values over 20 or 10 pg/ml suggest an ACTH dependent cause of CS. 2. HDDST -for distinguishing ACTHdependent from ACTHindependent CS. This test distinguishes pituitary from ectopic sources of ACTH with SZ and SP from 60% to 80% when a cutoff of plasma cortisol suppression above 50% is used.
3. CRH stimulation test -for distinguishing pituitary from ectopic sources of ACTH [increase above the baseline in ACTH 50%, SZ 86% and SP 95%; vs. cortisol 20%, SZ 91% and SP 95%; in evaluated time points (ACTH 15-30 min; cortisol 1545 min)].
Desmopressin and other tests under investigation [1-4].
Imaging methods are of less importance than labora tory confirmation of the diagnosis of pituitary CS. MRI of the pituitary with gadolinium enhancement currently exhibits a sensitivity of approximately 6070% in identi fying a pituitary microadenoma and should be the imag ing modality of choice. In selected cases, T2weighted MR images (the signal intensity of pituitary adenomas is slightly hyperintense) can be of use when a tumor is not demon strated on standard T1contrasted images (hypointense). Approximately 5% of pituitary microadenomas can take up gadolinium becoming isointense to the normal pituitary gland [4] . Dynamic MR imaging and MRI which involves acquiring thin image sections of 1mm thickness may be a better solution compared with standard MR imaging [5] .
When differential diagnostic tests indicate the pitu itary CS, and MRI cannot determine the pituitary ade noma, as in our case, the next step is IPSS. Early major series reported the procedure to be 100% sensitive and specific for the diagnosis of pituitarydependent Cushing's disease when using threshold central; peripheral ACTH ratios of 2:1 before, and central: peripheral ACTH ratios of 3:1 after the administration of CRH. New data indicate that false negative results after IPSS procedures are signif icantly more common than previously appreciated, and that a negative IPSS does not rule out a pituitary source [6, 7, 8] . Some patients with a false negative IPSS response exhibited a robust increase in peripheral ACTH level after CRH, as in the case of our patient, suggesting that the production of ACTH by the pituitary adenoma was not adequately sampled and perhaps either was not drain ing into the petrosal venous system or had been diluted by nonpituitary venous blood. Transsphenoidal explo ration should be considered in all patients with unsuc cessful IPS catheterizations after negative body imaging if other endocrine evaluation is consistent with a pitui tary source [6] . An intersinus ratio of 1.4 or greater has been suggested as being consistent with the ipsilateral localization of a microadenoma. Recommendations for ipsilateral hemihypophysectomy, in the absence of a clear tumor being visualized at operation, on the basis of the lateralizing data from inferior petrosal sinus sampling are hard to substantiate since in 20-50% of cases the tumor may be contralateral [7] . Because of the dilution of ACTH in the jugular vein, (C/P) internal jugular vein sampling ratios are lower than IPSS ratios in patients with CS. An arbitrary criterion set at 100% specificity (C/P >1.7 before or >2.0 after CRH) during IJV sampling [8] .
There are four reasons for the lack of histological con firmation of adenoma resection. First, an ACTH adenoma may have been present and either resected or compromised but not processed for pathological analysis. Examples may include instances when abnormal tissue is reported to be lost in suction or when pituitary gland exploration may cause inadvertent vascular compromise and necrosis of the hypersecreting adenoma. Second, an ACTH adenoma may have been resected, processed for pathological anal ysis, but not identified by the pathologist on pathological sections. Third, an ACTH adenoma may have been present but not surgically removed secondary to surgical inaccessi bility via a transsphenoidal approach, the invasive nature of the tumor, or inadequate exploration of the sellar contents. Fourth, one must consider the possibility of misdiagnosis, that hypercortisolemia is due to an ectopic source of ACTH and patients failed to achieve remission [9] . For patients in whom a discrete microadenoma cannot be located by sellar exploration, total or partial hypophysectomy may be indicated. Tumor resection leads to corticosteroid defi ciency because the remaining normal corticotroph cells have been suppressed by a longstanding hypercortisolism. As the result, hypocortisolism provides an index of sur gical success.
The literature suggests that the persistent postopera tive morning serum cortisol levels of less than 50 nmol/l is associated with remission and a low recurrence rate of approximately 10% at 10 years. A persistent serum corti sol level above 140nmol/l for up to six weeks requires fur ther evaluation. When serum cortisol levels are between 50 and 140 nmol/l, the patient can be considered in remis sion because the serum cortisol level falls more gradu ally, possibly reflecting a transient adrenal autonomy, but requires further followup [10] . In our case, pituitary cor ticotroph adenoma was surgically removed with postop erative hypocortisolism and iatrogenic hypopituitarism.
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